Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from JD Health International, Inc. ( (HK:6618) ) is now available.
JD Health International Inc. has scheduled a board meeting for March 5, 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ended December 31, 2025, and to consider whether to recommend a final dividend. The outcome of this meeting will shape the company’s capital return decisions and provide investors with an updated view of its financial performance and strategic progress.
Management will also host a conference call on the same day at 5:00 pm Beijing/Hong Kong time to discuss the 2025 financial results with analysts and investors. The call underscores the company’s effort to maintain active communication with the market and may offer additional insight into operating trends and its positioning within the competitive digital healthcare sector.
The most recent analyst rating on (HK:6618) stock is a Hold with a HK$74.00 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.
More about JD Health International, Inc.
JD Health International Inc. is a Cayman Islands-incorporated company listed in Hong Kong that operates in the online healthcare and health services industry. It focuses on providing digital medical and wellness services through its platforms, targeting consumers in Mainland China and other key markets in the region.
Average Trading Volume: 7,547,217
Technical Sentiment Signal: Buy
Current Market Cap: HK$194.6B
For an in-depth examination of 6618 stock, go to TipRanks’ Overview page.